Plasma and cerebrospinal fluid concentrations of pentazocine in patients: assay by mass fragmentography

Publisher Website
Google Scholar
Abstract
Mass fragmentography has been used for the determination of low concentrations of pentazocine in blood plasma and cerebrospinal fluid (csf) after intravenous administration of a 30 mg dose to eight patients undergoing neurosurgery under general anaesthesia. A pharmacokinetic analysis based upon mean plasma levels indicated a half-life of 134 min. Lumbar csf levels of pentazocine increased rapidly with mean values from about 3 ng ml−1 at 5 min to 10 ng ml−1 at 30 min and to about 15 ng ml−1 at 90–120 min. The possibility of repeated analyses of drug concentrations in the csf represents an important step towards the correlation of chemical data with clinical effects for centrally acting drugs.